We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Provence Technologies and Provepharm Invest EUR 4 Million in their New Head Office

News   Jan 30, 2014

 
Provence Technologies and Provepharm Invest EUR 4 Million in their New Head Office
 
 
 

RELATED ARTICLES

Scientists Produce a Potential Vitamin and Alzheimer’s Drug in Yeast

News

By engineering and optimizing baker's yeast, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) has for the first time exploited the potential of making ergothioneine in yeast in a bio-based fashion.

READ MORE

Importance of Salt in Drug Manufacture

News

Researchers are examining how salt modifies surface interactions in chromatography, a key technique in the creation of drugs. This could be a step towards simplifying drug manufacture.

READ MORE

Converting Woodchips Into Pharmaceutical Ingredients

News

Researchers have developed a method to produce pharmaceutically relevant compounds in just a few steps – with water as the only waste product, using renewable woodchips as starting material.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE